Search - tctmd.com

Displaying 321 - 340 of 511

Sort: Relevancy | Date

News Daily News

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Michael O'Riordan

January 16, 2020

News Daily News

Community Death Rates Following Type 2 MI Speak to Lack of Treatments, Trials

Yael L. Maxwell

January 10, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Daily News

New AUC for Cardiac Imaging Follow-up in Congenital Heart Disease

Michael O'Riordan

January 10, 2020

News Daily News

EACTS Offers to Help to Resolve EXCEL Controversy, as CRF Launches Review

Michael O'Riordan

January 08, 2020

News Daily News

EACTS Calls for Independent Left Main CAD Evidence Review, Urges ESC Input

Shelley Wood

December 20, 2019

News Daily News

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

Michael O'Riordan

December 20, 2019

Presentation

Response by David Taggart, MD, PhD to the EXCEL Statement

Presenter: David Taggart

December 19, 2019

Taggart Rebuts EXCEL Response, Insisting on Retraction

News Daily News

Taggart Rebuts EXCEL Response, Insisting Concerns Over MI and Mortality Remain

Michael O'Riordan

December 18, 2019

News Features

EXCEL Investigators Respond to Data Suppression Claims as Debate Erupts Online

Michael O'Riordan

December 12, 2019

News Daily News

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

Michael O'Riordan

December 10, 2019

News Daily News

Uninformed Consent? Most Patients Misunderstand True Benefits of PCI

Michael O'Riordan

November 29, 2019

News Opinion Off Script AHA 2019

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

Ajay Kirtane, MD, SM

November 12, 2019

News Daily News

STEMI Mortality Unaffected by Weekend, Weeknight, or Holiday Admission in France

Michael O'Riordan

October 31, 2019

News Daily News

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Michael O'Riordan

October 17, 2019

News Daily News

DAPT Cuts Saphenous Vein Graft Failure After CABG: Meta-analysis

Michael O'Riordan

October 17, 2019

News Conference News

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

Michael O'Riordan

October 07, 2019

News Opinion Fellow Talk

What I Am Most Looking Forward to at TCT 2019

Mahesh V. Madhavan, MD

September 18, 2019

News Daily News

Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors

L.A. McKeown

September 16, 2019

News Conference News ESC 2019

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

L.A. McKeown

September 09, 2019

Advertisement

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Community Death Rates Following Type 2 MI Speak to Lack of Treatments, Trials

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

New AUC for Cardiac Imaging Follow-up in Congenital Heart Disease

EACTS Offers to Help to Resolve EXCEL Controversy, as CRF Launches Review

EACTS Calls for Independent Left Main CAD Evidence Review, Urges ESC Input

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

Response by David Taggart, MD, PhD to the EXCEL Statement

Taggart Rebuts EXCEL Response, Insisting Concerns Over MI and Mortality Remain

EXCEL Investigators Respond to Data Suppression Claims as Debate Erupts Online

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

Uninformed Consent? Most Patients Misunderstand True Benefits of PCI

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

STEMI Mortality Unaffected by Weekend, Weeknight, or Holiday Admission in France

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

DAPT Cuts Saphenous Vein Graft Failure After CABG: Meta-analysis

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

What I Am Most Looking Forward to at TCT 2019

Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content